SCHEMBL20757909

SCHEMBL20757909

C=Cc1ccnc2[nH]cc(/C(C=N)=C/C=N)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24672101 0.81 LRRK2 (0.46) —
SCHEMBL24485904 0.70 CCNK (0.42) —
SCHEMBL24672118 0.69 ROCK1 (0.56) —
SCHEMBL20758357 0.69 ROCK1 (0.51) —
SCHEMBL24672417 0.67 ROCK2 (0.57) —
SCHEMBL24673115 0.66 ROCK1 (0.59) —
SCHEMBL24672931 0.66 ROCK1 (0.61) —
SCHEMBL24672095 0.66 CDC42BPB (0.62) —
SCHEMBL20757850 0.66 CDC42BPB (0.63) —
SCHEMBL26349932 0.64 AURKA (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019034890-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2019-02-21 — — WO disclosed
Send feedback